Biotech Connection Singapore

[Event information from JLABS Singapore] 𝗛𝗲𝗿𝗱𝗶𝗻𝗴 𝗰𝗮𝘁𝘀: 𝗕𝘂𝘀𝗶𝗻𝗲𝘀𝘀 𝗱𝗲𝘃𝗲𝗹𝗼𝗽𝗺𝗲𝗻𝘁 𝗳𝗼𝗿 𝗹𝗶𝗳𝗲 𝘀𝗰𝗶𝗲𝗻𝗰𝗲 𝗰𝗼𝗺𝗽𝗮𝗻𝗶𝗲𝘀 The goal of life science business development professionals is to optimize optionality and long-term value at each stage of its company’s life. What are the ins-and-outs of making a partnership? How do you determine the direction that will add the most value to your company? All the way from California, we are pleased to host an event led by Lesley Stolz, Regional VP of Early Innovation Partnering at Johnson & Johnson Innovation, on her signature session titled Herding cats: Business development for life science companies. Register now to hear from Lesley and industry business development professionals on fundamental BD skills to help you successfully evaluate and manage strategic alliances and other potential growth opportunities. Date: Tuesday, September 24 Time: 3:30PM - 7:00PM (Registration begins at 3:30PM) Location: Guoco Midtown Network Hub (Level 2), 126 Beach Road, Singapore 189772 Please find details and register for the event here: https://lnkd.in/gt_V8v99

NTU CoS Innovation Day 2024 The NTU College of Science (CoS) comprises the School of Physical and Mathematical Sciences (SPMS), School of Biological Sciences (SBS), School of Chemistry, Chemical Engineering and Biotechnology (CCEB), and Asian School of the Environment (ASE). This inaugural NTU CoS Innovation Day will bring together selected research experts from all the Schools to share about their scientific discoveries and technological solutions to address the needs of industry and society. Join us to learn about their innovation and to hear from Xora Innovation and SGInnovate on the ins and outs of translation and commercialisation of technologies! 📅: 23 October 2024, Wednesday 🕓: 8:30am to 3.30pm 📍: Nanyang Technological University, School of Biological Sciences, SBS Classroom 1 (Level 1)    60 Nanyang Drive, Singapore 637551 ✍ Click the following link to find out more and register: https://lnkd.in/gqhCH_ek #science #innovation

We recently partnered SGInnovate for the 2nd run of the Biotech Entrepreneur Community of Practice Roundtable with Tuyen Ong, CEO of Ring Therapeutics and CEO-Partner of Flagship Pioneering. This invite-only mentoring session was focused on helping founders and c-suite level executives of startups learn from the experiences of Tuyen Ong, a seasoned bioentrepreneur. He started the session answering the burning questions prepared by a number of the participants, followed by focusing on career planning, career development and fundraising. He also gave personalised advice and feedback to participants who sought help. We would like to thank our participants for being very active in the discussions. This enabled everyone to learn from one another and it definitely made the session a more enjoyable one! Once again, we greatly appreciate Tuyen Ong for mentoring biotech entrepreneurs in Singapore. We hope to continue this partnership with you! We would also like to thank our co-organisers: Vanessa Phua and Jerry Lui. #biotech #bioentrepreneurship #mentorship #founder

BCS Career Interviews – So you want to work in IP? IP is important for biotech companies and an alternative route after academia. How does someone enter this industry? What does daily work entail? In this interview article, Anni Wang, Ding Jie ANG and Seng Koon L. discuss their experiences in #IPinbiotech! Read the article here: https://lnkd.in/gycVAPrv #IP #lifesciences #biotech

Are you ready to take your expertise in drug development to the next level? Join us for our lunchtime workshop on Biomarker Discovery and Target Product Profile (TPP) Development co-organised by Merck Group Singapore and Biotech Connection Singapore! 🎯 Why Attend? Biomarkers play a pivotal role in the drug development process, guiding everything from initial discovery to clinical validation. This workshop by Merck's David Loong and Eng Hwa Yeo, PhD will provide you with cutting-edge insights on: Biomarker discovery: Understand the critical role biomarkers play in identifying therapeutic targets and predicting patient response. Learn the importance of developing robust assays for biomarker validation to ensure reliability and reproducibility. Learn how they contribute to defining TPP. TPP development: Learn about the key elements of a TPP, including safety, efficacy and patient population. Master the creation of a TPP that aligns with both regulatory requirements and market needs, ensuring your product’s success. Case Studies & Real-World Applications: Analyze real-world examples to understand the challenges and solutions in biomarker and TPP development. Q&A: Learn from the panel discussion by David Loong, Eng Hwa Yeo, PhD and Phyllis Xiu Li Gan. 📅: 12 September 2024, Thursday 🕓: 11:30am to 1.30pm (Refreshments provided) 📍: NSG Biolab Site 1, 21 Biopolis Rd, # 02-03/05 Click the following link to register: https://bit.ly/3yYxUje

What should founders know about fundraising in today’s competitive landscape? 💡 Last week, Gunderson Dettmer and Biotech Connection Singapore hosted a session packed with valuable insights. Jonathan Pentzien expertly distilled the fundamentals of venture financing, followed by a compelling discussion with our Therapeutics Lead Wen Qi Ho and MissionBridge’s Ritika Khetawat on what founders should consider before fundraising. Key takeaways: 𝗧𝗲𝗮𝗺 𝗺𝗮𝘁𝘁𝗲𝗿𝘀: 👥 Investors look beyond the CEO. A strong team with expertise in key roles like discovery and research is crucial. 𝗣𝗮𝗿𝘁𝗻𝗲𝗿𝘀 𝗺𝗮𝘁𝘁𝗲𝗿: 🤝 The type of capital around the table can influence investor interest. 𝗗𝗶𝗳𝗳𝗲𝗿𝗲𝗻𝘁𝗶𝗮𝘁𝗶𝗼𝗻 𝗺𝗮𝘁𝘁𝗲𝗿𝘀: 🚀 A unique and competitive technology is essential to attract investors. A special thanks to co-organizers Brendan Sieow, Beverly Mok, Xun Hui Y. and Grace Wong! #clavystbio #venturefinancing #startups

BCS interview with Dr Damien Keogh, founder and CEO of BluMaiden Biosciences. BluMaiden is revolutionizing drug discovery by combining AI and clinical data to fast-track drug development.  Read on as Dr Keogh discusses his experience starting and growing a #techbio company in Singapore. Read the article here: https://lnkd.in/gduR-cFR #biotech #techbio #AI #startup #drugdiscovery

We would like to thank everyone who joined us at the "Biotech Fundraising: Opportunities and Challenges" event, hosted by Gunderson Dettmer Singapore and Biotech Connection Singapore last week! We had the privilege of having Jonathan Pentzien, Managing Partner at Gunderson Dettmer Singapore deliver a masterclass on venture financing basics, focusing on key fundraising considerations for early-stage biotech startups. The following fireside chat comprised of our esteemed panelists: Wen Qi Ho, Therapeutics Lead at ClavystBio and Ritika Khetawat, Founder at MissionBridge, with Jonathan Pentzien as the moderator. The panel shared the different perspectives of a fundraiser and an investor when it came to the expectations, challenges and best practices in biotech fundraising. We are grateful to our three speakers for sharing their expertise and insights, and for answering all the difficult questions from the audience! 🙏 Special thanks to our co-organisers: Grace Wong from Gunderson Dettmer and Patricia Lee from ClavystBio. We hope to work with you again! Do check out Gunderson Dettmer and Gunderson Dettmer Asia's Linkedin page for more information! Headquartered in Silicon Valley, Gunderson Dettmer’s Singapore office is consistently recognized by Pitchbook’s Global League tables as the “most active venture capital law firm” in Southeast Asia and India. Gunderson represents life sciences clients headquartered around the world, from founders who are spinning intellectual property out of universities to venture-backed and public companies, as well as venture capital and growth equity firms focused on investing in those industries. Beverly Mok | Xun Hui Y. | Andrew Lee | Sungmin Shin | Zara Chung | James Ho | Brendan Sieow

6th IAS Frontiers in Genome Engineering Conference The 6th IAS Frontiers in Genome Engineering Conference will be held at the School of Chemistry, Chemical Engineering and Biotechnology (CCEB), NTU from 13-15 Nov 2024. The conference is part of the conference series launched in 2017 and had been hosted in a few cities like Seoul, Beijing and Kobe. Celebrating the revolutionary CRISPR-Cas system, this conference explores its transformative impact on biotechnology and biomedical science, from its roots in microbial immunity to its 2020 Nobel Prize-winning applications in genome editing. As we venture beyond CRISPR, the conference also highlights emerging genome engineering technologies, offering a platform for cutting-edge research, novel tools, and collaborative innovation. The meeting aims to foster global and regional dialogue in genome engineering and will bring together a diverse audience of academic researchers, industry experts, and government policymakers. Please find attached the conference poster and detailed information via the conference website here: https://lnkd.in/g6hEvmWB 📅: 13-15 November 2024, Thursday 🕓: Full Day (Exact timing to be confirmed) 📍: Nanyang Technological University, CCEB     62 Nanyang Drive, CCEB Lecture Theatre (Basement 2)    N1.2-B201, Singapore 637459 ✍ Click the following link to register now! https://lnkd.in/gSXMF3Xa

[Event information from JLABS Singapore] JLABS Singapore presents Meet with Panacea Venture Thursday, 29 August, 3:30pm-6:30pm co11ab Novena, Lee Kong Chian School of Medicine, Clinical Sciences Building 11 Mandalay Road # 16-01 In Johnson & Johnson Innovation – JLABS Singapore’s ongoing Meet with Capital series, JLABS will be partnering with co11ab Novena on Thursday, 29 August to host their next event where they will have the pleasure of introducing Panacea Venture to the Singaporean life science community. Joining the discussion will also be industry experts from Vertex Growth and PairX Bio to share perspectives and insights on the current investment trends and landscape in Singapore and the region. And more excitingly, JLABS Singapore will be making a special announcement on the awardee of the Singapore Navigator! Please find details and register for the event here: https://lnkd.in/gMf92Mun #biotech #venturecapital #entrepreneurship #APAC #investmentlandscape #lifescience